Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bryan Giraudo Insider Profile
4 Followers
Bryan Giraudo, Director at Protagonist Therapeutics, holds 472.75K shares in Gossamer Bio (Ticker: GOSS), holds 18.00K shares in Protagonist Therapeutics (Ticker: PTGX). Most recently, Bryan Giraudo Sold ― shares of Gossamer Bio on Mar 28, 2024 for an estimated value of 7.39K.
Profitable Transactions
7 out of 14 Profitable Transactions
Average Return
+27.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Bryan Giraudo holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Dec 03, 2019 - Dec 03, 2020
Return:+354.10%
The most profitable trade made by Bryan Giraudo
Bryan Giraudo's Trading History
Protagonist Therapeutics
Dec 03, 2019
Director
Informative Buy
45.60K
$469.62K
Gossamer Bio
Mar 28, 2024
COO/CFO
Informative Sell
7.39K
$349.83K
List of latest transactions for each holding click on a transaction to see Bryan Giraudo's performance on stock
You May Also Like
Bryan Giraudo insider profile FAQ
What is the percentage of profitable transactions made by Bryan Giraudo?
The percentage of profitable transactions made by Bryan Giraudo is 50%.
What is the average return per transaction made by Bryan Giraudo?
The average return per transaction made by Bryan Giraudo is 27.80%.
What stocks does Bryan Giraudo hold?
Bryan Giraudo holds: PTGX, GOSS stocks.
What was Bryan Giraudo’s latest transaction?
Bryan Giraudo latest transaction was an Informative Sell of $7.39K.
What was Bryan Giraudo's most profitable transaction?
Bryan Giraudo’s most profitable transaction was an Informative Buy of PTGX stock on December 3, 2019. The return on the trade was 354.10%.
What is Bryan Giraudo's role in Protagonist Therapeutics?
Bryan Giraudo's role in Protagonist Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.